Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2125 records

$457,488.00

Apr 1, 2013
Description:

Discovery and Characterization of UROD Inhibitors for Cancer Therapy

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4

$596,320.00

Apr 1, 2013
Description:

An autologous cell therapy approach to treat Duchenne muscular dystrophy using engineered muscle tissue derived from induced pluripotent stem cells.

Organization: Canadian Institutes of Health Research
Location: Montréal, Quebec, CA H3T 1C5

$509,868.00

Apr 1, 2013
Description:

Chitosan-siRNA nanoparticles for gene silencing in Atherosclerosis and Cancer

Organization: Canadian Institutes of Health Research
Location: Montréal, Quebec, CA H3T 1J4

$187,556.00

Apr 1, 2013
Description:

Transcriptional control of myelin gene expression and myelination by oligodendrocytes in young adult and aged mice

Organization: Canadian Institutes of Health Research
Location: Saskatoon, Saskatchewan, CA S7N 5A2

$738,083.00

Apr 1, 2013
Description:

The role of bacterial silencing proteins in virulence gene expression

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 1A1

$454,685.00

Apr 1, 2013
Description:

Temperature measurement in cortical bone and bone marrow during magnetic resonance guided focused ultrasound thermo-therapy in a porcine model

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 1A1

$2,266,046.00

Apr 1, 2013
Description:

Toward epigenetic therapy for colon cancer

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5S 1A1

$509,660.00

Apr 1, 2013
Description:

Targeted nanomedicines for gene therapy applications.

Organization: Canadian Institutes of Health Research
Location: Waterloo, Ontario, CA N2L 3G1

$90,000.00

Apr 1, 2013
Description:

Screening for Novel NS5B-Inhibitors: Toward Selective and Potent Hepatitis C Virus (HCV) Therapy.

Organization: Canadian Institutes of Health Research
Location: Edmonton, Alberta, CA T6G 2E1

$409,127.00

Apr 1, 2013
Description:

Small Molecule Inhibitors of Phagocytosis as Replacement Therapy for IVIG

Organization: Canadian Institutes of Health Research
Location: Toronto, Ontario, CA M5G 2C4